98%
921
2 minutes
20
The term pachychoroid, derived from the Greek word pachy meaning "thick," refers to a choroidal phenotype characterized by increased choroidal thickness, dilated outer choroidal vessels (pachyvessels), and attenuation of the overlying Sattler layer and choriocapillaris. Initially recognized in central serous chorioretinopathy, this phenotype is now acknowledged as the underlying pathophysiological basis for a broader spectrum of retinal disorders, including pachychoroid pigment epitheliopathy, pachychoroid neovasculopathy, polypoidal choroidal vasculopathy, focal choroidal excavation, peripapillary pachychoroid syndrome, pachydrusen and pachychoroid geographic atrophy. Collectively referred to as the pachychoroid disease spectrum, these entities share common features such as structural choroidal remodeling, choroidal vascular hyperpermeability, and outer retinal or retinal pigment epithelial changes. The introduction of enhanced depth imaging and swept-source optical coherence tomography (OCT), OCT angiography, and ultra-widefield indocyanine green angiography has significantly expanded the understanding of choroidal anatomy and function, leading to the identification of additional features such as vortex vein abnormalities, intervortex venous anastomoses, and localized choroidal hypoperfusion. These insights have prompted a reevaluation of disease classification. Moreover, pachychoroid-driven neovascularization demonstrates distinct therapeutic behaviour, including variable responses to anti-vascular endothelial growth factor agents and potential benefit from photodynamic therapy. We explore current controversies related to the etiopathogenesis, disease classification, and treatment of pachychoroid disorders, emphasizes the importance of multimodal imaging in accurate diagnosis, and proposes a clinically relevant algorithm to help ophthalmologists identify and manage true pachychoroid spectrum disorders effectively.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.survophthal.2025.08.013 | DOI Listing |
Retina
August 2025
Department of Ophthalmology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Purpose: This study aimed to investigate changes in choroidal thickness using widefield optical coherence tomography following anti-vascular endothelial growth factor (VEGF) therapy for neovascular age-related macular degeneration (AMD).
Methods: We examined 69 patients with unilateral neovascular AMD. All patients underwent three monthly intravitreal injections of anti-VEGF agents.
Ophthalmol Ther
September 2025
Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Introduction: This study investigated the long-term natural history of peripapillary pachychoroid syndrome (PPS), analyzing both morphological and functional outcomes.
Methods: This retrospective study included 24 eyes from 14 participants diagnosed with PPS. No interventions were administered.
Indian J Ophthalmol
September 2025
Department of Ophthalmology, Saarland University Medical Center, Homburg, Germany.
Purpose: The aim of the study was to evaluate optical coherence tomography (OCT) and indocyanine green angiography (ICGA) biomarkers in patients with chronic central serous chorioretinopathy (cCSC) as potential indicators of response to treatment with subthreshold nanosecond laser (NSL).
Methods: In this retrospective study, we examined 36 eyes of 32 cCSC patients after NSL. High response (HR) was defined as complete resolution of subretinal fluid (SRF) 3 months after first NSL treatment, full response (FR) as complete resolution of SRF, 3 months after the last NSL, with all NSL sessions occurring within 1 year from the first NSL.
Surv Ophthalmol
August 2025
University of Pittsburgh School of Medicine, Department of Medical Retina and Vitreoretinal Surgery, 203 Lothrop Street, Suite 800, Pittsburg, PA 15213.
The term pachychoroid, derived from the Greek word pachy meaning "thick," refers to a choroidal phenotype characterized by increased choroidal thickness, dilated outer choroidal vessels (pachyvessels), and attenuation of the overlying Sattler layer and choriocapillaris. Initially recognized in central serous chorioretinopathy, this phenotype is now acknowledged as the underlying pathophysiological basis for a broader spectrum of retinal disorders, including pachychoroid pigment epitheliopathy, pachychoroid neovasculopathy, polypoidal choroidal vasculopathy, focal choroidal excavation, peripapillary pachychoroid syndrome, pachydrusen and pachychoroid geographic atrophy. Collectively referred to as the pachychoroid disease spectrum, these entities share common features such as structural choroidal remodeling, choroidal vascular hyperpermeability, and outer retinal or retinal pigment epithelial changes.
View Article and Find Full Text PDFOphthalmic Surg Lasers Imaging Retina
August 2025
Pigmented epithelial detachment (PED) blowout in central serous chorioretinopathy (CSC) can present with intraretinal and subretinal fluid and hyperreflective foci, mimicking Type 3 macular neovascularization (MNV). Differentiating between pachychoroid neovasculopathy (PNV) and PED blowout is crucial for appropriate treatment. This report highlights the case of a 47-year-old male patient with chronic CSC and suspected PNV, experiencing persistent blurred vision despite nine intravitreal aflibercept 2 mg injections.
View Article and Find Full Text PDF